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Background:
The objective of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine (SSAI) task force on mechanical ventilation in adults with the acute respiratory distress syndrome (ARDS) is to formulate treatment recommendations based on available evidence from systematic reviews and randomised trials. Methods: This guideline was developed according to standards for trustworthy guidelines through a systematic review of the literature and the use of the Grading of Recommendations Assessment, Development and Evaluation system for assessment of the quality of evidence and for moving from evidence to recommendations in a systematic and transparent process. Results: We found evidence of moderately high quality to support a strong recommendation for pressure limitation and small tidal volumes in patients with ARDS. Also, we suggest positive endexpiratory pressure (PEEP) > 5 cm H2O in moderate to severe ARDS and prone ventilation 16/24 h for the first week in moderate to severe ARDS (weak recommendation, low quality evidence). Volume controlled ventilation or pressure control may be equally beneficial or harmful and partial modes of ventilatory support may be used if clinically feasible (weak recommendation, very low quality evidence). We suggest utilising recruitment manoeuvres as a rescue measure in catastrophic hypoxaemia only (weak recommendation, low quality evidence). Based on high-quality evidence, we strongly recommend not to use high-frequency oscillatory ventilation. We could find no relevant data from randomised trials to guide decisions on choice of FiO2 or utilisation of non-invasive ventilation.
Conclusion:
We strongly recommend pressure-and volume limitation and suggest using higher PEEP and prone ventilation in patients with severe respiratory failure.
An electronic version of this guideline can be accessed at www.ssai.info/guidelines/ • What other guideline statements are available on this topic? Recommendations for mechanical ventilation in ARDS can be found in UpToDate* and the surviving sepsis campaign guidelines † • Why was this guideline developed? This guideline was developed as part of a greater programme under SSAI to create a body of evidencebased guidelines relevant to Nordic anaesthesiologists. Guidelines for the management of the most common forms of organ failure in critical care are an important part of this work.
• How does this statement differ from existing guidelines? This guideline statement aims to provide Nordic anaesthesiologists with recommendations for the mechanical ventilation of patients with ARDS. Available evidence is presented in a transparent manner to stimulate informed decision making in clinical practice. Recommendations are presented in accord with the latest standards developed by the GRADE working group. The items listed may differ from those found in other guideline statements.
• Why does this statement differ from existing guidelines? The policy endorsed by SSAI is to issue guideline-statements that are informative and largely free of expert opinion.
Editorial comment: what this article tells us
The task force strongly recommends pressure and volume limitation and suggests using higher PEEP and prone ventilation in patients with severe respiratory failure. Recruitment manoeuvres may significantly improve oxygenation and lung aeration, particularly in the acute stage of ARDS, but clinical benefit has yet to be clearly proven except for prone position that may be regarded as a recruitment manoeuvre.
Management of the acute respiratory distress syndrome (ARDS) is of major importance in modern intensive care units (ICUs). According to recent surveys, patients with ARDS constitute 25-50% of patients in European intensive care units and with an associated mortality of 20-50%. Following its identification by Ashbaugh in 1967, 1 ARDS was defined by an American-European Consensus Conference in 1994. 2 This definition was recently revised in what is now known as the Berlin definition. 3 Briefly, ARDS is presently defined as hypoxemic respiratory failure, classified as mild (26.6 kPa < PaO2/FIO2 ≤ 40 kPa), moderate (13.3 kPa < PaO2/FIO2 ≤ 26.6 kPa), and severe (PaO2/FIO2 ≤ 13.3 kPa) ( Table 1 ). The pathophysiology of ARDS is an evolving concept that involves the inflammatory cascade, fluid dynamics, lung mechanics, and the pulmonary circulation. 4 Recently, both phenotypic and genotypic categorisation has added to our understanding of ARDS. 5, 6 Apart from lung mechanics, the manner in which pathophysiological insight will influence therapy in ARDS is still unclear.
Consequently, studies of ARDS suffer from heterogeneity regarding the underlying disease process and also the timing of inclusion following ARDS development. Clinical trials of mechanical ventilation have focussed on how to achieve the right balance between adequate oxygenation and ventilation in patients with ARDS, and simultaneously avoiding further damage to the lungs. This guideline is authored by a task force on mechanical ventilation in adults with ARDS. The work was initiated by the Clinical Practice Committee of the Scandinavian Society of Anaesthesia and Intensive Care Medicine (SSAI), and it summarises best current available research evidence and provides recommendations according to new standards for trustworthy guidelines outlined by the Institute of Medicine and the Guideline Inter-national Network and according to methodology developed by the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group, now endorsed by the board of SSAI. [7] [8] [9] Other authoritative sources such as UpToDate and the Surviving Sepsis Campaign have also applied GRADE in their guidelines for mechanical ventilation of adults in acute respiratory distress syndrome.
10,11

Methods
Guideline task force
Members of the guideline task force were selected by the national societies of anaesthesiology in Denmark, Finland, Iceland, Norway, and Sweden, following invitation from the Clinical Practice Committee of the SSAI.
GRADE
In our development of recommendations, we used the GRADE system for formulating clinical questions, assessing the quality of evidence, generating anticipated absolute effects, and for moving from evidence to recommendations. Briefly, clinical questions were formulated in the so-called PICO format, which identify the relevant patient population and/or clinical problem (P), the intervention (I) under scrutiny as well as the comparator (C), and important outcomes (O) ( Table 2) .
For literature review, we first searched the McMaster PLUS database to identify high-quality systematic reviews. If no recent high quality systematic reviews were found, we searched the following databases: PubMed, Embase, Google Scholar, and the Cochrane Library for evidence (Online Appendix). When available, published systematic reviews were used to identify relative effect estimates and assess the quality of evidence for the important outcomes. In keeping with the GRADE methodology, the quality of evidence for an intervention (i.e. our confidence in the effect estimates) was rated down for identified risks of bias (e.g. due to lack of blinding, or early termination of studies), inconsistency (i.e. unexplained heterogeneity), and indirectness (e.g. different patient populations or use of surrogate outcomes) and imprecision (wide confidence interval around the effect estimate). Importantly, however, when the outcome in question was death at any stage, we did not downgrade evidence due to lack of blinded outcome assessment. Accordingly, quality of evidence was rated from 'high' to 'very low'. Recommendations were based on the PICO questions where we identified randomised trials, and this guideline does not offer any recommendations that are not defined by these. Also, we do not propose any recommendation based on nonrandomised trials, observational studies, or physiological knowledge. When moving from evidence to recommendations, four factors were considered and integrated: Benefits and harms, quality of evidence, values and preferences (of patients or their proxies), and cost considerations. GRADE classifies recommendations as strong when virtually all informed patients or proxies would choose the recommended management strategy. Weak recommendations, which reflect a close call between benefits and harms, uncertainty regarding treatment effects, questionable cost-effectiveness, or variability in values and Table 1 The Berlin definition of the Acute Respiratory Distress Syndrome (ARDS) 3 .
ARDS is characterised by the following four criteria:
1. Lung injury of acute onset, within 1 week of an apparent clinical insult and with progression of respiratory symptoms 2. Bilateral opacities on chest imaging not explained by other pulmonal pathology (e.g. pleural effusions, lung collapse, or nodules) 3. Respiratory failure not explained by heart failure or volume overload 4. Decreased arterial PO2/FiO2 ratio:
• Mild ARDS: ratio is 201-300 mmHg (≤ 39.9 kPa) • Moderate ARDS: 101-200 mmHg (≤ 26.6 kPa) • Severe ARDS: ≤ 100 mmHg (≤ 13.3 kPa) (A minimum PEEP of 5 cm H2O is required; it may be delivered non-invasively with CPAP to diagnose mild ARDS). Table 2 Clinical problems and PICO questions used to assess evidence relevant to this guideline statement.
Informal clinical question PICO Question
Population (P)
Outcomes (O)
1. Should pressure and volume limitation (PVL) be used in patients with ARDS?
• Should small tidal volumes always be used in ARDS?
• Should plateau pressure always be kept low? (i.e. preferences, apply when fully informed patients would choose different management strategies. 9, 12 The group agreed upon the recommendations in this document. Strong recommendations were given the wording 'we recommend', and weak recommendations 'we suggest'. Table 3 gives recommendation statements and key information underlying the recommendations. We provide GRADE evidence profiles and Forest plots of meta-analyses in the Online Appendix. The baseline risk presented in tables was consistently derived from the control arms in the trials included. Recommendations are mainly based on absolute risk of death, being the most critical patient important outcome. Death at some pre-specified time-point following inclusion is also the primary end point of the included studies. Time to follow-up is variable, however, ranging from 28-30 days to 180 days (or ICU and hospital mortality). With respect to secondary end points, these are extremely diverse, inconsistently reported, and often difficult to interpret with any accuracy.
Results
Recommendation 1
Pressure and volume limitation
We recommend use of pressure limitation and small tidal volumes in patients with ARDS (strong recommendation, moderate quality evidence). The rationale for limiting ventilator pressures and volumes in ARDS has been detailed in numerous reviews and is supported by experimental and clinical evidence. 13 A recent Cochrane review was used for our analysis. 14 We found evidence of moderately high quality for a large effect on mortality. Quality of evidence was only downgraded for inconsistency because of significant heterogeneity between trials (effect on mortality mainly observed in trials where mean plateau pressure was > 31 cm H2O in the control groups) (Online Appendix; Table S1 , Fig. S1 ).
Recommendation 2
Positive end-expiratory pressure We suggest using positive end-expiratory pressure (PEEP) to improve oxygenation and to prevent atelectasis in all mechanically ventilated patients with respiratory failure (weak recommendation, low quality evidence). The evidence summarised in two recent systematic reviews suggests that any mortality benefit of higher PEEP (> 5 cm H2O) is limited to patients with moderate to severe ARDS (GRADE 2B). 15, 16 High PEEP is safe and does not impact on length of stay in patients with moderate to severe ARDS (Online Appendix; Table S2 , Fig. S2 ).
Recommendations 3-4
FiO2, non-invasive ventilation
We decided not to issue recommendations for these questions, as we could find no trial data to support firm decisions on choice of fraction of inspired oxygen (FiO2) or non-invasive ventilation. To the best of our knowledge, there are no trials testing the upper and lower limits and potential harms of either the FiO2 or the arterial oxygen content in patients with acute respiratory failure. There are no randomised clinical trials that compare non-invasive ventilation to invasive ventilation in ARDS.
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Recommendation 5
Ventilator mode 1. We suggest that both pressure and volumeregulated ventilation may be used in mechanically ventilated patients with ARDS (weak recommendation, low quality evidence). We were able to identify three randomised trials that compared volume controlled ventilation (VC) with pressure controlled ventilation (PC). [18] [19] [20] In general, the quality of evidence for the identified outcomes was very low, and precludes any recommendation of one mode over the other, although one study with severe methodological issues (experimental and control different from start; one group sicker) demonstrated lower hospital mortality with PC. 20 We suggest that both modes of ventilation are equally beneficial or detrimental, and that both modes can be used at the discretion of the attending physician. 2. We suggest that partial modes of ventilatory support may be used if clinically feasible (weak recommendation, very low quality 21 identified two randomised trials that compared airway pressure release ventilation with pressure controlled ventilation 22 or synchronised intermittent mandatory ventilation with pressure support. 23 Any conclusion is hampered by lack of adequate control groups in the chosen RCTs and also lack of power to assess mortality, but additional data described in the McMullen review, including experimental studies, suggest that partial support modes of ventilation may improve oxygenation, improve haemodynamics, and decrease need for sedation (Online Appendix; Table S3 , Fig. S3 ).
MECHANICAL VENTILATION IN ARDS
Recommendation 6
Prone ventilation
We suggest use of ventilation in the prone position for 16/24 h for the first week in moderate to severe ARDS (weak recommendation, low quality evidence). This recommendation is based on the review by Abroug et al. 24 with data from Guérin et al. 25 added to the dataset. There is considerable heterogeneity between included trials. Also, the routine use of neuromuscular blockade (NMB) in later trials of prone ventilation has caused us to rate down the quality of the evidence due to indirectness. Our reasoning is that NMB may alter lung mechanics sufficiently to caution against a general application of these results to ARDS patients who are ventilated without NMB. However, prone ventilation appears to be safe and may reduce time on mechanical ventilation compared with ventilation in the supine position only (Online Appendix; Table S4 , Fig. S4 ).
Recommendation 7
Recruitment manoeuvres
We suggest utilising recruitment manoeuvres as a rescue measure against catastrophic hypoxaemia (i.e. when hypoxia in itself is considered to be immediately life threatening) (weak recommendation, low quality evidence). Hodgson et al. recently reviewed the evidence for use of recruitment manoeuvres in ARDS. 26 The authors found no evidence that recruitment manoeuvres reduce mortality or length of ventilation in patients with ARDS. However, a more recent meta-analysis showed that recruitment manoeuvres did significantly increase oxygenation above baseline levels for a short period of time in four of the five studies that measured oxygenation 27 (Online Appendix; Table S5 , Fig. S5 ). ‡
Recommendation 8
High-frequency oscillatory ventilation
We recommend against the use of high-frequency oscillatory ventilation (HFOV) (strong recommendation, high-quality evidence). This recommendation is based on the systematic review from Sud et al. 28 with the addition of trial data from two new multicentre trials. 29, 30 One study included in the systematic review was removed by us because it is a study in paediatric patients. 31 There is considerable heterogeneity between included trials with respect to the primary end point. However, two large, recently published studies that compared HFOV to volume and pressure-limited ventilation found either no effect or harm from HFOV (Online Appendix; Table S6 , Fig. S6 ).
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Discussion
In adopting the GRADE-system for its guideline development, the SSAI has emphasised that guidelines should inform readers about current best evidence and avoid advice based solely on expert opinion. Also, this guideline statement avoids reference to observational studies, a huge part of the critical care literature. Such studies are well suited for generating hypotheses, and are therefore an important source of information for the Scandinavian Critical Care Trials Group (SCCTG).
We could use existing high-quality systematic reviews of randomised trials for most of this work. However, in assessing the evidence base for ventilation modes and FiO2, no relevant metaanalyses or systematic reviews were found. Also, ‡Following submission of this guideline, Suzumura et al. published an updated systematic review of the evidence for utilisation of recruitment maneuvers in ARDS. 27 These data will be fully incorporated into later versions of this guideline.
we updated and revised a dataset from an existing meta-analysis of high-frequency oscillatory ventilation to include to later high-quality trials. Existing systematic reviews of non-invasive ventilation do not include data relevant to this guideline. 17 Both primary and secondary end points are inconsistently reported in the ARDS literature. In selecting the most relevant outcomes across several studies, even mortality can be difficult to assess because authors have chosen different length of follow-up, some studies report only percentages (instead of numbers), and even mortality rates adjusted for severity are used in some reports. In such cases, we have sought to present data as simply as possible, using absolute numbers whenever possible and a conservative calculation of numbers when percentages have been used in original papers.
The redefinition of hypoxaemic respiratory failure into mild, moderate, and severe ARDS 3 simplifies study selection. Analysis is complicated, however, due to significant variability between published studies with respect to the severity of illness in patients included in each study, and also by the heterogeneous nature of any underlying disease and the timing of inclusion of patients following development of ARDS. Examples include volume-limited ventilation, where data indicate that survival benefit is only demonstrable in studies where plateau pressures in the control arm exceeded 31 cm H2O (Online Appendix, Fig. S1 ). Also, PEEP > 5 cm H2O only confers benefit (oxygenation) to patients with moderate to severe ARDS, and any benefit is lost in mild ARDS (Online Appendix; Table S2 ).
Why develop Nordic guidelines for intensive care medicine? Intensive care medicine, and particularly mechanical ventilation, has a longstanding tradition in Nordic anaesthesiology, and much of the early pioneering work was done by anaesthetists in the Nordic countries. [32] [33] [34] It is therefore only natural that SSAI develops guidelines and standards that emphasise the role of anaesthesiology in intensive care medicine. Also, across the Nordic societies, there is considerable professional, cultural, and economic homogeneity. This is important because there are many shared values, preferences, and resource considerations, which are important elements in the GRADE system throughout our societies.
The guideline process serves to inform us that, despite advances, there are many areas of our practice that are characterised by a paucity of hard evidence. Ideally, guideline developers work in concert with trialists to make informed choices when allocating resources for costly investigations. Close collaboration with the SCCTG is therefore essential for further progress.
A limitation of this work is that we have restricted our recommendations to those that can be deduced from randomised trials only. There are limited data available from randomised trials for several treatment options (e.g. various ventilator modes with spontaneous breathing, FiO2). This leaves the clinician who cares for ARDS patients and who applies our guideline with the choice between a conservative approach based on available evidence from randomised trials, and careful use of new treatment options and physiological targets. We cannot exclude that available observational studies could have provided valuable evidence to inform some of our recommendations. Indeed observational studies may result in moderate to high-quality evidence according to the GRADE system although such cases are few and far between. 35 Although the rationale for many treatment options have been that the intervention has been shown to improve physiological parameters (e.g. oxygenation), the history of critical care research has often shown that such a strategy may be faulty. Indeed, a recent before and after study in mechanically ventilated patients (mixed ICU population) indicates that a conservative oxygenation strategy was not harmful and may be beneficial. 36 Also, we have learned that it is not obvious which part of our pathophysiological insight will provide therapeutic strategies that benefit patients; the practice of gentle ventilation derives from the 'baby lung' concept that was developed from experimental and clinical studies of lung mechanics in ARDS. 37 In clinical practice, gentle ventilation will often challenge us to accept blood gases that are far from 'normal', yet the benefit to patients has been clearly demonstrated. 38 Conversely, recruitment manoeuvres may significantly improve oxygenation and lung aeration, particularly in the acute stage of ARDS, available literature does not dictate a strong recommendation. 26 We believe that it is correct to avoid giving recommendations based on physiological data only, and hope that gaps in our list of recommendations may stimulate Scandinavian multi-centre trials.
Conclusion
This and the accompanying paper represent the first attempt by SSAI to develop a clinical guideline that adheres to the principles developed by the GRADE working group. We invite readers of this guideline to carefully review the recommendations that have been derived from the evidence presented herein and apply them in clinical practice to the benefit of their patients.
Supporting information
Additional Supporting Information may be found in the online version of this article: Table S1 . Summary of evidence for mortality at different times of follow up for pressure and volume limited ventilation (PVL) in ARDS. Table S2 . Summary of evidence for utilisation of PEEP in ARDS patients. Stratified for severity of illness. Table S3 . Summary of evidence for modes of ventilation in ARDS. 
